Skip to main content
OpenTrials

Clinical trial condition

Corticobasal Degeneration (CBD)

Explore clinical trials studying Corticobasal Degeneration (CBD). Study availability and eligibility vary by location and protocol.

9 public trials 4 recruiting studies
Refine in advanced search Browse all conditions

Corticobasal Degeneration (CBD) trial results

Recruiting

ARTFL LEFFTDS Longitudinal Frontotemporal Lobar Degeneration (ALLFTD)

NCT04363684

Conditions
Amyotrophic Lateral Sclerosis, Basal Ganglia Diseases, Behavioral Variant Frontotemporal Dementia (bvFTD), +41 more
Locations
  • University of Alabama Birmingham Birmingham, Alabama, United States
  • University of California, Los Angeles Los Angeles, California, United States
  • University of California, San Diego San Diego, California, United States
  • University of California San Francisco San Francisco, California, United States
View all 27 locations
View Trial Details
Completed

4-Repeat Tauopathy Neuroimaging Initiative - Cycle 2

NCT02966145

Conditions
Basal Ganglia Diseases, Brain Diseases, Central Nervous System Diseases, +26 more
Locations
  • University of California, San Diego (UCSD) San Diego, California, United States
  • University of California, San Francisco (UCSF) San Francisco, California, United States
  • Johns Hopkins University Baltimore, Maryland, United States
  • Harvard University - Massachusetts General Hospital Charlestown, Massachusetts, United States
View Trial Details
Completed

ADDIA Proof-of-Performance Clinical Study

NCT03030586

Conditions
Alzheimer Disease, Alzheimer Disease (AD), Basal Ganglia Diseases, +31 more
Locations
  • Cliniques Universitaires Saint-Luc Brussels, Belgium
  • ERASME Hospital Brussels, Belgium
  • Hopitaux Universitaires de Strasbourg Strasbourg, Alsace, France
  • Centre Hospitalier Universitaire de Besançon Besançon, France
View all 13 locations
View Trial Details
Completed

Advancing Research and Treatment for Frontotemporal Lobar Degeneration (ARTFL)

NCT02365922

Conditions
Amyotrophic Lateral Sclerosis, Amyotrophic Lateral Sclerosis (ALS), Aphasia, +51 more
Locations
  • University of Alabama Birmingham, Alabama, United States
  • University of California, Los Angeles Los Angeles, California, United States
  • University of California, San Diego San Diego, California, United States
  • University of California, San Francisco San Francisco, California, United States
View all 17 locations
View Trial Details
Completed

Safety Study of TPI-287 to Treat CBS and PSP

NCT02133846

Conditions
Basal Ganglia Diseases, Brain Diseases, Central Nervous System Diseases, +23 more
Locations
  • University of Alabama Birmingham, Alabama, United States
  • University of California, San Francisco San Francisco, California, United States
View Trial Details

Related conditions